The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease

Rotigotine is a new, non-ergot dopamine receptor agonist (DRA) formulated as a transdermal drug delivery system. This article reviews the clinical efficacy and tolerability of Rotigotine transdermal patch in Parkinson's disease (PD) and discusses the results of clinical trials of Rotigotine in...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: Marina Romanovna Nodel
Формат: Artigo
Язык:Russo
Опубликовано: IMA-PRESS LLC 2013-11-01
Серии:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Предметы:
parkinson's disease
levodopa
dopamine receptor agonists
rotigotine
transdermal patch
therapy
compliance
fluctuations
dyskinesis
Online-ссылка:https://nnp.ima-press.net/nnp/article/view/257
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы